These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38042670)

  • 1. Involved-site Radiotherapy Delineation Dilemmas in the Treatment of Adult Hodgkin Lymphoma: Turkish Society for Radiation Oncology Hematological Oncology, Pediatric Oncology and TBI Study Group Case-based Questionnaire Review (TROD 03-005).
    Yilmaz MT; Kamer S; Agaoglu F; Hayran KM; Yildiz F
    Clin Oncol (R Coll Radiol); 2024 Feb; 36(2):80-86. PubMed ID: 38042670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
    Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma.
    Hoppe BS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):40-5. PubMed ID: 25863752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
    Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.
    Aznar MC; Girinsky T; Berthelsen AK; Aleman B; Beijert M; Hutchings M; Lievens Y; Meijnders P; Meidahl Petersen P; Schut D; Maraldo MV; van der Maazen R; Specht L
    Acta Oncol; 2017 Apr; 56(4):608-613. PubMed ID: 28105886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation.
    Kaidar-Person O; Nissen HD; Yates ES; Andersen K; Boersma LJ; Boye K; Canter R; Costa E; Daniel S; Hol S; Jensen I; Lorenzen EL; Mjaaland I; Nielsen MEK; Poortmans P; Vikström J; Webb J; Offersen BV
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):20-29. PubMed ID: 32988717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
    Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
    Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Pilot Curriculum for International Education of Lymphoma Management Using E-Contouring.
    Mailhot Vega RB; Ishaq OF; Ahmed I; Rene L; Amendola BE; Hu KS
    J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging and management of localized non-Hodgkin's lymphomas: variations among experts in radiation oncology.
    Tsang RW; Gospodarowicz MK; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):643-51. PubMed ID: 11849785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
    Abbassi LM; Goudjil F; Arsène-Henry A; Dendale R; Kirova YM
    Cancer Radiother; 2019 Dec; 23(8):922-925. PubMed ID: 31257097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma.
    Walker AJ; Chirindel A; Hobbs RF; Huynh-Le MP; Moore JA; Cho SY; Terezakis SA
    Pract Radiat Oncol; 2015; 5(4):219-27. PubMed ID: 26146182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy.
    Pinnix CC; Wirth A; Milgrom SA; Andraos TY; Aristophanous M; Pham M; Hancock D; Ludmir EB; Gunther JR; Fanale MA; Oki Y; Nastoupil L; Chuang HH; Mikhaeel NG; Dabaja BS
    Leuk Lymphoma; 2018 Nov; 59(11):2650-2659. PubMed ID: 29616834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin's lymphoma. A case study.
    Lütgendorf-Caucig C; Fotina I; Gallop-Evans E; Claude L; Lindh J; Pelz T; Knäusl B; Georg D; Pötter R; Dieckmann K;
    Strahlenther Onkol; 2012 Nov; 188(11):1025-30. PubMed ID: 23053144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.
    Tseng YD; Pankuch M; Mohindra P; McGee L; Rossi C; Flampouri S; Hajj C; Molitoris JK; Chang JH; Tsai H; Stevens C; Rosen L; Vargas C; Hartsell W
    Am J Clin Oncol; 2021 Jun; 44(6):269-274. PubMed ID: 33852456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of follicular lymphoma: updated role and new rules.
    Yahalom J
    Curr Treat Options Oncol; 2014 Jun; 15(2):262-8. PubMed ID: 24700284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ILROG guideline of radiation therapy for nodal lymphomas: involved site radiation therapy].
    Oguchi M; Hasegawa M; Ishibashi N; Isobe K; Imai M; Ejima Y; Kasuya T; Katayama E; Sasai K; Soejima T; Hayafuchi N;
    Rinsho Ketsueki; 2014 Oct; 55(10):1903-11. PubMed ID: 25297754
    [No Abstract]   [Full Text] [Related]  

  • 18. Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma.
    Piva C; Genovesi D; Filippi AR; Balducci M; Barra S; Buglione M; Busetto M; Ciammella P; Franzone P; De Sanctis V; Simontacchi G; Fusella M; Ricardi U;
    Pract Radiat Oncol; 2015; 5(6):383-9. PubMed ID: 26547826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.
    Genovesi D; Cèfaro GA; Vinciguerra A; Augurio A; Di Tommaso M; Marchese R; Ricardi U; Filippi AR; Girinsky T; Di Biagio K; Belfiglio M; Barbieri E; Valentini V
    Strahlenther Onkol; 2011 Jun; 187(6):357-66. PubMed ID: 21603989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma.
    Mazonakis M; Lyraraki E; Damilakis J
    Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.